Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months

J Clin Oncol. 2013 Aug 10;31(23):e401-3. doi: 10.1200/JCO.2012.47.7455. Epub 2013 Jun 24.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Ablation Techniques
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / surgery*
  • Combined Modality Therapy
  • Disease Progression
  • Drug Administration Schedule
  • Humans
  • Indoles / administration & dosage*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / surgery*
  • Male
  • Pyrroles / administration & dosage*
  • Radiosurgery / methods
  • Sunitinib

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Sunitinib